| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/03/2003 | CA2450947A1 Black soybean polysaccharides |
| 01/03/2003 | CA2450828A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | CA2450550A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | CA2450478A1 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2450174A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | CA2449844A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004344 Thrombin or factor Xa inhibitors |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004308 Anticoagulants |
| 01/02/2003 | US20030004212 Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists |
| 01/02/2003 | US20030004194 Method for treating fibrotic diseases or other indications VI |
| 01/02/2003 | US20030004191 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| 01/02/2003 | US20030004186 Anticoagulants; cardiovascular disorders; central nervous system disorders |
| 01/02/2003 | US20030004167 Imidazo-heterobicycles as factor Xa inhibitors |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003082 Use of poly-Glu,Tyr and T cells treated therewith for neuroprotective therapy |
| 01/02/2003 | US20030003056 Useful in in vivo applications sucha as embolizing blood vessels and/or reversibly sterilizing mammals |
| 01/02/2003 | EP1270558A1 "Compound for the treatment of atherosclerotic-thrombotic pathological conditions" |
| 01/02/2003 | EP1270551A1 Urea derivatives with antiproteolytic activity |
| 01/02/2003 | EP1270032A1 Device for parenterally delivering solid drug compositions |
| 01/02/2003 | EP1270004A1 Diuretics containing gamma-tocotrienol |
| 01/02/2003 | EP1268861A2 Diagnosis of diseases associated with dna transcription |
| 01/02/2003 | EP1268857A2 Diagnosis of diseases associated with gene regulation |
| 01/02/2003 | EP1268817A1 Human pyruvate dehydrogenese phosphatase |
| 01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/02/2003 | EP1268786A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268775A1 The high bone mass gene of 11q13.3 |
| 01/02/2003 | EP1268768A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/02/2003 | EP1268559A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268537A1 Crystal structure of the (aml1 runt domain)/(cbfbeta) heterodimer and the ternary complex with dna |
| 01/02/2003 | EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268503A1 O-glucosylated benzamide sglt2 inhibitors and method |
| 01/02/2003 | EP1268502A1 O-aryl glucoside sglt2 inhibitors and method |
| 01/02/2003 | EP1268498A1 Cardioprotective phosphonates and malonates |
| 01/02/2003 | EP1268489A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 01/02/2003 | EP1268481A2 Kinase inhibitors as therapeutic agents |
| 01/02/2003 | EP1268472A1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 01/02/2003 | EP1268469A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 01/02/2003 | EP1268463A2 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268452A1 BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268432A1 ISOQUINOLONE INHIBITORS OF FACTOR Xa |
| 01/02/2003 | EP1268428A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors |
| 01/02/2003 | EP1268413A2 Substituted biphenyl derivatives |
| 01/02/2003 | EP1268407A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/02/2003 | EP1267954A1 Medical devices suitable for gene therapy regimens |
| 01/02/2003 | EP1267943A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 01/02/2003 | EP1267942A2 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 01/02/2003 | EP1267931A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 01/02/2003 | EP1267915A2 Methods of treating diseases with activated protein c |
| 01/02/2003 | EP1267896A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death |
| 01/02/2003 | EP1267887A2 The use of cocoa procyanidins combined with acetylsalicyclic acid as an anti-platelet therapy |
| 01/02/2003 | EP1267883A2 Bile secretion promoting composition containing a prostaglandin |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267835A1 D and l etherlipid stereoisomers and liposomes |
| 01/02/2003 | EP1267828A2 Pharmaceutical preparations |
| 01/02/2003 | EP1210944A4 Blood plasma replacement solution |
| 01/02/2003 | EP1030831A4 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 01/02/2003 | EP0934265B1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| 01/02/2003 | EP0928195B1 Compositions for use in embolizing blood vessels |
| 01/02/2003 | EP0885007B1 Method for separating cells, especially platelets, and bag assembly therefor |
| 01/02/2003 | EP0863754B1 Hydrolysis-optimized lipid emulsions and use thereof |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/02/2003 | EP0662138B1 Long wap promoter for mammary expression of human protein c |
| 01/02/2003 | EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 01/01/2003 | CN1388118A Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn and use |
| 01/01/2003 | CN1387912A Prepn of polygelatine peptide injection |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants |
| 12/31/2002 | US6500851 Antithrombotic agents |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/31/2002 | US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 12/31/2002 | US6500809 Neural tissue edema is treated by circulating a hyperoncotic artificial cerebrospinal fluid in the cerebrospinal fluid pathway in the vicinity of edematous tissue to cause the edematous tissue to be dehydrated due to an oncotic gradient |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500472 For enriching foods or beverages, anemia treatment |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103024A2 Stabilized proteins with engineered disulfide bonds |
| 12/27/2002 | WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 12/27/2002 | WO2002102391A2 Composition comprising nanoparticulate spironolactone |
| 12/27/2002 | WO2002102383A1 Aqueous cilostazol preparation for injection |
| 12/27/2002 | WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002087626A9 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same |
| 12/27/2002 | WO2002083696A3 Novel cyclo azaphospha hydrocarbons |